MetaVia Inc
MTVA
NASDAQ
Biotechnology
$1.49
USD
+0.03 (+2.05%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $9.62M
Volume 69.2K
Revenue
$0
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
$-14.45M
TTM
— YoY
Operating Cash Flow
$-15.84M
TTM
— YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
YoY Growth | — | — | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 2.0 | 1.6 | 1.8 | 1.9 | 1.9 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 4.3 | 3.5 | 2.0 | 4.0 | 5.4 |
Operating Income | -4.3 | -3.5 | -2.0 | -4.0 | -5.4 |
EBITDA | -4.3 | -3.5 | -2.0 | -4.0 | -5.4 |
Other Income / Expense | 0.2 | -0.1 | 0.0 | 0.1 | -0.0 |
Total Other Income / Expense | 0.3 | 0.1 | 0.1 | 0.2 | 0.1 |
Income Before Income Taxes | -4.0 | -3.4 | -1.9 | -3.8 | -5.3 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -4.0 | -3.4 | -1.9 | -3.8 | -5.3 |
Consolidated Net Income / Loss | -4.0 | -3.4 | -1.9 | -3.8 | -5.3 |
Net Income Attributable to Common Shareholders | -4.0 | -3.4 | -1.9 | -3.8 | -5.3 |
Basic EPS | -$2.87 | -$1.54 | -$0.77 | -$0.79 | -$0.90 |
Diluted EPS | -$2.87 | -$1.54 | -$0.77 | -$0.79 | -$0.90 |
Basic Shares Outstanding | 1.4M | 2.2M | 2.5M | 4.9M | 5.9M |
Diluted Shares Outstanding | 1.4M | 2.2M | 2.5M | 4.9M | 5.9M |